Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Guglielmi

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|November 1, 2006
Metabolic factors affecting residual beta cell function assessed by C-peptide secretion in patients with newly diagnosed type 1 diabetesA Picardi, N Visalli, A Lauria, et al.
Leukemia|February 24, 2001
Idarubicin intensified BUCY2 regimen in allogeneic unmanipulated transplant for high-risk hematological malignanciesA Mengarelli, A P Iori, C Guglielmi, et al.
Blood|July 29, 1998
Expression of myeloid markers lacks prognostic impact in children treated for acute lymphoblastic leukemia: Italian experience in AIEOP-ALL 88-91 studiesM C Putti, R Rondelli, M G Cocito, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Time to relapse has prognostic value in patients with aggressive lymphoma enrolled onto the Parma trialC Guglielmi, F Gomez, T Philip, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|October 5, 2005
A two year observational study of nicotinamide and intensive insulin therapy in patients with recent onset type 1 diabetes mellitusA Crinó, R Schiaffini, P Ciampalini, et al.
British Journal of Haematology|September 12, 1998
Immunophenotype of adult and childhood acute promyelocytic leukaemia: correlation with morphology, type of PML gene breakpoint and clinical outcome. A cooperative Italian study on 196 casesC Guglielmi, M P Martelli, D Diverio, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|August 17, 2006
The effects of calcitriol and nicotinamide on residual pancreatic beta-cell function in patients with recent-onset Type 1 diabetes (IMDIAB XI)D Pitocco, A Crinò, E Di Stasio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2000
CD56 expression is an indicator of poor clinical outcome in patients with acute promyelocytic leukemia treated with simultaneous all-trans-retinoic acid and chemotherapyF Ferrara, F Morabito, B Martino, et al.
Bone Marrow Transplantation|July 28, 2009
Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the Chronic Leukemia Working Party of the EBMTY Chalandon, J R Passweg, C Schmid, et al.
Bone Marrow Transplantation|August 26, 1998
Umbilical cord blood transplant from HLA-mismatched unrelated donor in high-risk leukemiaW Arcese, A P Iori, M Screnci, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|November 1, 2006
Metabolic factors affecting residual beta cell function assessed by C-peptide secretion in patients with newly diagnosed type 1 diabetesA Picardi, N Visalli, A Lauria, et al.
Leukemia|February 24, 2001
Idarubicin intensified BUCY2 regimen in allogeneic unmanipulated transplant for high-risk hematological malignanciesA Mengarelli, A P Iori, C Guglielmi, et al.
Blood|July 29, 1998
Expression of myeloid markers lacks prognostic impact in children treated for acute lymphoblastic leukemia: Italian experience in AIEOP-ALL 88-91 studiesM C Putti, R Rondelli, M G Cocito, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Time to relapse has prognostic value in patients with aggressive lymphoma enrolled onto the Parma trialC Guglielmi, F Gomez, T Philip, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|October 5, 2005
A two year observational study of nicotinamide and intensive insulin therapy in patients with recent onset type 1 diabetes mellitusA Crinó, R Schiaffini, P Ciampalini, et al.
British Journal of Haematology|September 12, 1998
Immunophenotype of adult and childhood acute promyelocytic leukaemia: correlation with morphology, type of PML gene breakpoint and clinical outcome. A cooperative Italian study on 196 casesC Guglielmi, M P Martelli, D Diverio, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|August 17, 2006
The effects of calcitriol and nicotinamide on residual pancreatic beta-cell function in patients with recent-onset Type 1 diabetes (IMDIAB XI)D Pitocco, A Crinò, E Di Stasio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2000
CD56 expression is an indicator of poor clinical outcome in patients with acute promyelocytic leukemia treated with simultaneous all-trans-retinoic acid and chemotherapyF Ferrara, F Morabito, B Martino, et al.
Bone Marrow Transplantation|July 28, 2009
Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the Chronic Leukemia Working Party of the EBMTY Chalandon, J R Passweg, C Schmid, et al.
Bone Marrow Transplantation|August 26, 1998
Umbilical cord blood transplant from HLA-mismatched unrelated donor in high-risk leukemiaW Arcese, A P Iori, M Screnci, et al.
Pageof 8